Arcataur Capital Management LLC Sells 47 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Arcataur Capital Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,097 shares of the healthcare conglomerate’s stock after selling 47 shares during the period. Arcataur Capital Management LLC’s holdings in UnitedHealth Group were worth $641,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Capital Insight Partners LLC raised its position in UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares in the last quarter. Tealwood Asset Management Inc. acquired a new position in UnitedHealth Group in the third quarter worth about $2,905,000. Vantage Investment Partners LLC raised its position in UnitedHealth Group by 42.2% in the first quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock worth $75,247,000 after purchasing an additional 45,173 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Finally, Maryland State Retirement & Pension System increased its holdings in shares of UnitedHealth Group by 0.6% during the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock worth $35,126,000 after buying an additional 469 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.7 %

NYSE:UNH opened at $560.82 on Friday. The firm has a market capitalization of $517.87 billion, a price-to-earnings ratio of 36.54, a PEG ratio of 1.67 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $584.16 and its two-hundred day moving average price is $536.49. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm posted $6.56 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.50%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Truist Financial restated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Wells Fargo & Company increased their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Barclays decreased their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.